Feedback / Questions
alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic
https://www.prnewswire.com/news-releases/anixa-biosciences-advances-breast-cancer-vaccine-toward-phase-2-after-positive-phase-1-results-cytovance-selected-for-cgmp-manufacturing-302730803.html
Apr 1, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next